|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.32 CAD | +1.59% |
|
+8.47% | -20.99% |
| May. 09 | DIAGNOS Inc. announced that it expects to receive CAD 1.5 million in funding | CI |
| May. 06 | Diagnos Inc. Announces to Present Cutting-Edge AI Solutions for Retinal Health at ARVO 2024 | CI |
DIAGNOS Inc. reported earnings results for the first quarter ended June 30, 2022. For the first quarter, the company reported sales was CAD 0.149014 million compared to CAD 0.075961 million a year ago. Net loss was CAD 0.717158 million compared to CAD 0.720023 million a year ago.
Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -20.99% | 18.03M | |
| -12.88% | 191B | |
| +1.53% | 167B | |
| +3.89% | 155B | |
| +8.07% | 103B | |
| +36.59% | 83.67B | |
| +11.45% | 82.06B | |
| -6.43% | 71.76B | |
| -17.20% | 54.05B | |
| -8.68% | 43.53B |
DIAGNOS INC. 